Two new I‐Corps™ at NIH cohorts in 2016

Apply to PA-16-019 by December 10, 2016 (1st cohort) Or March 21, 2016 (2nd cohort)


The I-Corps™ at NIH program, supported by President Obama’s Strategy for American Innovation, aims to support biomedical innovation and translation, with the goal of expediting the development and commercialization of a range of technologies to address the leading causes of death and disability in the United States. I-Corps™ participants will receive lessons on how to build a scalable business model as well as entrepreneurial trainings, and mentorship opportunities.  In addition, modest funding will be provided to teams to assist them in translating their ideas from the lab into a viable product on the market and to help them avoid common failure points.

NHLBI Small Business programs support the development of new technologies from lab to market.

For more information or questions on the I-Corps™ at NIH program, please visit or contact:

Get To Know NHLBI:

Jennifer C. Shieh, PhD

Small Business Coordinator & Program Director

More about I-Corps™:

NSF I-Corps™ graduates: Magnamosis

I‐Corps™: BCN Biosciences

I‐Corps™: Huffington Post

The NHLBI SBIR/STTR Programs provide support for small businesses developing and commercializing novel technologies and products to promote the prevention, diagnosis, and treatment of heart, lung, blood, and sleep diseases and disorders. The NHLBI provides grant and contract funding for research and development of technologies related to the mission of NHLBI. For more information about the NHLBI SBIR/STTR Program, including funding opportunities, visit our web page.@NHLBI_SBIR  |  Sign up or adjust your subscription at the NHLBI-SBIR subscriber page

Posted in AZBio News, Capital, Opportunities.